Zevra Therapeutics Ownership | Who Owns Zevra Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Zevra Therapeutics Ownership Summary

Zevra Therapeutics is owned by 77.06% institutional investors, 1.28% insiders, and 21.66% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.75% of ZVRA shares. Fidelity Contrafund is the top mutual fund, with 4.98% of its assets in Zevra Therapeutics shares.

ZVRA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Zevra Therapeutics	77.06%	1.28%	21.66%
Sector	Healthcare Stocks	244.59%	12.11%	-156.70%
Industry	Biotech Stocks	379.61%	11.70%	-291.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	5.11M	8.75%	$73.26M
Fmr	4.92M	8.42%	$70.49M
Woodline partners lp	4.79M	8.19%	$68.63M
Vanguard group	3.31M	5.91%	$29.61M
Vanguard capital management	2.64M	4.52%	$37.84M
Altium capital management lp	1.85M	3.87%	$15.43M
Nantahala capital management	1.80M	3.08%	$25.78M
State street	1.68M	2.88%	$24.12M
Geode capital management	1.54M	2.64%	$22.10M
D. e. shaw	1.31M	2.24%	$18.74M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Altium capital management lp	1.85M	4.38%	$15.43M
Retirement planning co of new england	634.41K	3.27%	$9.10M
Propel bio management	253.54K	1.90%	$3.64M
Stonepine capital management	258.70K	1.74%	$3.71M
Kingdon capital management	775.00K	1.14%	$11.11M
Mystic asset management	352.11K	1.08%	$5.05M
Nantahala capital management	1.80M	0.86%	$25.78M
683 capital management	855.00K	0.60%	$12.26M
Phocas financial	295.91K	0.59%	$4.24M
Pharvision advisers	66.73K	0.36%	$634.63K

Top Buyers

Holder	Shares	% Assets	Change
Fmr	4.92M	0.00%	1.70M
Woodline partners lp	4.79M	0.21%	1.33M
Blackrock funding, inc. /de	5.11M	0.00%	652.39K
Arrowstreet capital, limited partnership	597.16K	0.00%	597.16K
D. e. shaw	1.31M	0.01%	460.49K

Top Sellers

Holder	Shares	% Assets	Change
Rubric capital management lp	-	-	-1.96M
Aigh capital management	-	-	-1.20M
Point72 asset management	-	-	-1.16M
Nantahala capital management	1.80M	0.86%	-724.46K
Velan capital investment management lp	-	-	-715.00K

New Positions

Holder	Shares	% Assets	Change	Value
Arrowstreet capital, limited partnership	597.16K	0.00%	597.16K	$8.56M
Swedbank ab	439.41K	0.01%	439.41K	$6.30M
Algert global	418.55K	0.07%	418.55K	$3.98M
Allspring global investments	216.87K	0.00%	216.87K	$2.99M
Globeflex capital l p	191.90K	0.35%	191.90K	$2.75M

Sold Out

Holder	Change
Thompson investment management	-1.00
Sjs investment consulting	-3.00
Ifp advisors	-4.00
Capital performance advisors llp	-40.00
Navalign	-50.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	166	5.06%	45,008,347	8.94%	77	1.54%	95	28.38%	38	-24.00%
Mar 31, 2026	70	-58.33%	11,315,248	-70.34%	20	0.44%	36	-56.63%	20	-60.00%
Dec 31, 2025	114	-35.96%	23,766,788	-40.43%	42	0.80%	57	-46.73%	30	-21.05%
Sep 30, 2025	169	42.02%	39,764,013	12.97%	72	1.76%	101	55.38%	37	37.04%
Jun 30, 2025	125	6.84%	36,154,652	1.99%	65	1.54%	68	15.25%	28	-3.45%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Contrafund	2.94M	4.98%	488.63K
Vanguard Total Stock Mkt Idx Inv	1.90M	3.21%	130.20K
Vanguard Morn Total Stk Mkt Idx Investor	1.90M	3.21%	130.20K
Vanguard MStar Total Stk Mkt Idx Invest	1.90M	3.20%	-
iShares Russell 2000 ETF	1.49M	2.52%	-26.50K
Fidelity Contrafund Commingled Pl Cl S	1.14M	1.92%	182.13K
Vanguard Institutional Extnd Mkt Idx Tr	680.93K	1.15%	1.20K
Janus Henderson Small/Md Cp Gr Alpha ETF	670.08K	1.13%	-
Fidelity Contrafund K6	629.81K	1.07%	102.31K
International Biotechnology Ord	606.45K	1.02%	100.42K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 14, 2026	Thompson Rahsaan	Chief Legal & Compliance	Sell	$474.77K
Aug 10, 2026	Watton Corey Michael	-	Sell	$138.38K
Jun 22, 2026	Thompson Rahsaan	Chief Legal & Compliance	Sell	$438.30K
May 11, 2026	Thompson Rahsaan	Chief Legal & Compliance	Sell	$20.27K
Feb 09, 2026	McFarlane Neil F.	President and CEO	Sell	$125.19K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	1
2026 Q2	-	2
2026 Q1	-	8
2025 Q4	-	1
2025 Q3	3	-

ZVRA Ownership FAQ

Who Owns Zevra Therapeutics?

Zevra Therapeutics shareholders are primarily institutional investors at 77.06%, followed by 1.28% insiders and 21.66% retail investors. The average institutional ownership in Zevra Therapeutics's industry, Biotech Stocks , is 379.61%, which Zevra Therapeutics falls below.

Who owns the most shares of Zevra Therapeutics?

Zevra Therapeutics’s largest shareholders are Blackrock funding, inc. /de (5.11M shares, 8.75%), Fmr (4.92M shares, 8.42%), and Woodline partners lp (4.79M shares, 8.19%). Together, they hold 25.36% of Zevra Therapeutics’s total shares outstanding.

Does Blackrock own Zevra Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Zevra Therapeutics.

Who is Zevra Therapeutics’s biggest shareholder by percentage of total assets invested?

Altium capital management lp is Zevra Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.38% of its assets in 1.85M Zevra Therapeutics shares, valued at 15.43M$.

Who is the top mutual fund holder of Zevra Therapeutics shares?

Fidelity Contrafund is the top mutual fund holder of Zevra Therapeutics shares, with 4.98% of its total shares outstanding invested in 2.94M Zevra Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools